Update on sepsis: Pathophysiology and treatment

Acta Clinica Belgica

Volumn 55, Issue 2, 2000, Pages 79-87

  Vincent, J L ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Cytokines; Inflammatory response; Nitric oxide

Indexed keywords

CYTOKINE; ICOSANOID; NITRIC OXIDE; OXYGEN RADICAL; THROMBOCYTE ACTIVATING FACTOR;

ARACHIDONIC ACID METABOLISM; ARTICLE; COMPLEMENT SYSTEM; IMMUNE RESPONSE; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; SEPSIS;

EID: 0033767754     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.2000.11754275     Document Type: Article

References (71)

1. Sepsis and septic shock: Update on definitions
2. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
3. Dear Sirs, I'm sorry to say that I don't like you
4. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: Incidence, morbidities and outcomes in surgical ICU patients
5. The Italian SEPSIS study: Preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock
6. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome
7. Pro- and anti-inflammatory cytokines during acute severe pancreatitis: An early and sustained response, although unpredictable of death. Parisian Study Group on Acute Pancreatitis
8. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction
9. Circulating levels of cytokines and their endogenous modulators in patients with severe congestive heart failure due to coronary artery disease or heart failure
10. Multiple organ failure syndrome
11. The gastrointestinal tract. The 'undrained abscess' of multiple organ failure
12. Serum cytokine levels in human septic shock: Relation to multiple-systems organ failure and mortality
13. Sepsis and serum cytokine concentrations
14. C-reactive protein as a diagnostic test of sepsis in the critically ill
15. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit
16. C-reactive protein as an indicator of sepsis
17. High serum procalcitonin concentration in patients with sepsis and infection
18. Procalcitonin as a marker for the early diagnosis of neonatal infection
19. Procalcitonin in diagnosis of severe infections
20. Procalcitonin - A sepsis parameter in severe burn injuries
21. Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein
22. Procalcitonin as a marker of infection in the intensive care unit
23. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease
24. Elevated serum neopterin level: Its relation to endotoxemia and sepsis in patients with major burns
25. The sepsis syndrome in a Dutch university hospital
26. Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group
27. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units
28. Customized probability models for early severe sepsis in adult intensive care patients
29. Has the mortality of septic shock changed with time?
30. APACHE II: A severity of disease classification system
31. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study
32. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
33. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicentric, prospective study
34. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling
35. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction
36. The cardiovascular response of normal humans to the administration of endotoxin
37. A single dose of endotoxin increases intestinal permeability in healthy humans
38. The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans
39. Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways
40. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of antiinflammatory agents
41. Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2
42. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock
43. Blood interleukin-10 levels parallel the severity of septic shock
44. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis
45. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin
46. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group
47. Detection of circulating tumor necrosis factor after endotoxin administration
48. Administration of anti-TNF antibody improves left ventricular function in septic shock patients
49. Interleukin-1 beta and tumor necrosis factor-alpha synergistically induce NO synthase in rat vascular smooth muscle cells
50. Anticachectin/TNF alpha monoclonal antibodies prevent septic shock during lethal bacteraemia
51. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor- in experimental gram-negative shock
52. Divergent efficacy of antibody to tumor necrosis factor- in intravascular and peritonitis models of sepsis
53. Double-blind randomised controlled trial of monoclonal antibody to human tumor necrosis factor in treatment of septic shock
54. Treatment of severe sepsis in patients with highly elevated IL-6 levels with anti-TNF monoclonal antibody MAK 195F: The RAMSES study
55. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein
56. p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock
57. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial
58. Interleukin-10 production during septicaemia
59. Blood interleukin-10 levels are correlated with the severity of septic shock
60. The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure
61. Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double-blind, placebo- controlled, multicenter clinical trial. BN 52021 Sepsis Study Group
62. Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 sepsis investigator group
63. The effects of ibuprofen on the physiology and survival of patients with sepsis
64. The effects of intravenous antioxidants in patients with septic shock
65. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double-blind study
66. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock
67. Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, delibant (CP-0127)
68. Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or post-surgical complications: A controlled, double-blind, randomized, multicenter study
69. Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy
70. Effects of NO on blood flow distribution and oxygen extraction capabilities during endotoxic shock
71. Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock